GFP Monoclonal Antibody (3E6) and 1 more item

The University of Virginia awarded contract A207_PO-0454101 to Life Technologies Corporation on July 3, 2026, for the procurement of specialized laboratory reagents and biological materials. The contract, valued at $618, encompasses two distinct line items for delivery to Jaeda Coutinho-Budd. The first line item specifies one unit of GFP Monoclonal Antibody (3E6) at a unit price of $396. The second line item provides one unit of SUPERaseIn RNase Inhibitor (20 U/uL, 2500 U) at a unit price of $222.46. These materials are typical of those used in molecular biology research and experimentation.

As a Virginia-based institutional procurement, this contract represents a straightforward purchase order transaction for research consumables. Life Technologies Corporation, the prime contractor, supplied these reagents to support the University of Virginia's research operations. The relatively modest contract value and single-transaction nature of the award indicate this constitutes a routine materials purchase rather than a comprehensive service or supply agreement. The specified delivery recipient and institutional context suggest these items support ongoing laboratory work within the university's research infrastructure.